Search

Hector W Alila

from Katy, TX
Age ~71
Get Report
Also known as:
Hector S Alila, Hector W Alia, Hector Avila, Alila Hector
Phone and address:
25706 Oakton Springs Dr, Katy, TX 77494
Related to:
Cynthia T Otieno, 43Vincent OtienoHector Avila, 59Tiffany G Otieno, 35Rhoebe Alila, 67G Steve Alila, 42Linda A Alila, 44Beatrice Otieno, 64Dorothy Nelly OtienoSuzanne A Alila, 37Nelly Dorothy Otieno, 38
Connected to:
Joseph R Alila, 68Ben Alilin, 88Nicholas M Alilio, 53Robert T Alilovich, 70Aaron Alim, 43Ahmad M Alim, 68Amin Alim, 37Faisal P Alim, 60Fareeah B Alim, 42Julius C Alim, 82

Hector Alila Phones & Addresses

  • 25706 Oakton Springs Dr, Katy, TX 77494
  • West Chester, PA
  • Baton Rouge, LA
  • 1268 Turnbury Ln, North Wales, PA 19454 (215) 661-1481 (215) 661-1781 (267) 613-8590
  • Gwynedd, PA
  • Houston, TX
  • Spring, TX
  • Fort Worth, TX
  • Richmond, CA
  • 1268 Turnbury Ln, North Wales, PA 19454 (215) 661-1481

Work

Position: Medical Professional

Education

Degree: Graduate or professional degree

Emails

h***[email protected]

Professional Records

License Records

Hector W Alila

Address:
North Wales, PA 19454
License #:
BV007752L - Expired
Category:
Veterinary Medicine
Type:
Veterinarian

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hector W. Alila
Treasurer, Vice-President
E G S Management Services LLC
Management Services, Nsk
1515 Beverly Rd, Philadelphia, PA 19138
Hector Alila
President
African Beauty Exports, Inc
1268 Turnbury Ln, North Wales, PA 19454
1 Frost Ct, Flemington, NJ 08822
Hector W. Alila
Director
H & B International, Inc
2742 Jeanetta St, Houston, TX 77063

Publications

Us Patents

Methods For Treatment Of Cystic Fibrosis

View page
US Patent:
6465494, Oct 15, 2002
Filed:
Aug 24, 2001
Appl. No.:
09/938786
Inventors:
Keith A. Earle - North Wales PA
Hector W. Alila - North Wales PA
Clark M. Whitehead - Warminster PA
W. Joseph Thompson - Doylestown PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A01N 4340
US Classification:
514344, 435196, 514851, 514522, 514307
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of cystic fibrosis.

Methods For Treatment Of Type I Diabetes

View page
US Patent:
6479493, Nov 12, 2002
Filed:
Aug 23, 2001
Appl. No.:
09/935802
Inventors:
Clark M. Whitehead - Warminster PA
Keith A. Earle - North Wales PA
Hector W. Alila - North Wales PA
W. Joseph Thompson - Doylestown PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K 3153
US Classification:
514241, 5142521, 51425506, 514307, 514311, 514357, 514365, 514381, 514394, 514400, 514406, 514419, 514427, 514461, 514866
Abstract:
Substituted condensation products of -benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of type I diabetes.

Methods For Treatment Of Inflammatory Bowel Disease

View page
US Patent:
6699894, Mar 2, 2004
Filed:
Sep 23, 2002
Appl. No.:
10/252286
Inventors:
Keith A. Earle - North Wales PA
Hector W. Alila - North Wales PA
Assignee:
OSI Pharmaceuticals, Inc. - Melville NY
International Classification:
A01N 4340
US Classification:
514357, 514307, 514311, 514381, 514382, 514383, 514365, 514394, 5142521, 424400
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of inflammatory bowel disease.

Method For Treating A Patient With Neoplasia Using Iressa

View page
US Patent:
6906064, Jun 14, 2005
Filed:
Jun 10, 2002
Appl. No.:
10/166940
Inventors:
W. Joseph Thompson - Doylestown PA, US
Hector W. Alila - North Wales PA, US
International Classification:
A61K031/535
A61K031/445
US Classification:
5142345, 514319
Abstract:
This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an inhibitor of human epidermal growth factor receptor tyrosine kinase and a cGMP-specific phosphodiesterase inhibitor.

Lytic Domain Fusion Constructs And Methods Of Making And Using Same

View page
US Patent:
8318899, Nov 27, 2012
Filed:
Jan 26, 2009
Appl. No.:
12/359906
Inventors:
Carola Leuschner - Baton Rouge LA, US
Hector Alila - Baton Rouge LA, US
Assignee:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College - Baton Rouge LA
Esperance Pharmaceuticals - Baton Rouge LA
International Classification:
C07K 14/00
A61K 38/16
US Classification:
530350, 530300, 4241981
Abstract:
The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.

Lytic Domain Fusion Constructs And Methods Of Making And Using Same

View page
US Patent:
8546535, Oct 1, 2013
Filed:
Mar 5, 2009
Appl. No.:
12/398965
Inventors:
Carola Leuschner - Baton Rouge LA, US
Hector Alila - Baton Rouge LA, US
Assignee:
Esperance Pharmaceuticals, Inc. - Baton Rouge LA
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College - Baton Rouge LA
International Classification:
C07K 5/00
US Classification:
530350, 530402
Abstract:
The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.

Method For Treating A Patient With Neoplasia By Treatment With A Gonadotropin Releasing Hormone Analog

View page
US Patent:
20020193286, Dec 19, 2002
Filed:
Apr 30, 2002
Appl. No.:
10/136140
Inventors:
Rifat Pamukcu - Spring House PA, US
Kerstin Menander - Meadowbrook PA, US
Hector Alila - North Wales PA, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
This invention provides a method or treating a patient with neoplasia by an adjuvant therapy that includes treatment with a gonadotropin-releasing hormone analog.

Methods For Treatment Of Scleroderma

View page
US Patent:
20030073711, Apr 17, 2003
Filed:
Aug 23, 2001
Appl. No.:
09/938160
Inventors:
Clark Whitehead - Warminster PA, US
Keith Earle - North Wales PA, US
Hector Alila - North Wales PA, US
W. Joseph Thompson - Doylestown PA, US
International Classification:
A61K031/497
A61K031/53
A61K031/435
A61K031/47
A61K031/415
US Classification:
514/277000, 514/252100, 514/256000, 514/241000, 514/307000, 514/311000, 514/396000, 514/381000, 514/407000, 514/415000, 514/443000
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of scleroderma.
Control profile
Hector W Alila from Katy, TX, age ~71 Get Report